Cell Dissociation Market Size, Share, Growth Analysis 2023-2029

The global cell dissociation market size was valued at USD 402.6 million in 2022 and is poised to grow at a significant CAGR of 12.5% during the forecast period 2023-29. The increased requirement for research and development in biopharmaceutical businesses is likely to drive the growth of the cell dissociation market during the forecast period. Furthermore, the favorable funding landscape for cancer research and the increasing incidence and prevalence of chronic and infectious diseases are expected to expand the cell dissociation market. Furthermore, rising interest in customized medicine and increased government funding for cell-based research are expected to support the development of the cell dissociation market.

View the detailed report description here- https://precisionbusinessinsights.com/market-reports/cell-dissociation-market

The cell dissociation market is segmented based on product, tissue, type, end user and geography.

By Product
o Enzymatic Dissociation Products
o Non-Enzymatic Dissociation Products
o Instruments

By Tissue
o Connective Tissues
o Epithelial Tissues
o Others (Skeletal and Muscles Tissues)

By Type
o Tissue Dissociation
o Cell Detachment

By End User
o Pharmaceutical and Biotechnology companies
o Research and Academics
o Other End Users

By Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

The Enzymatic Dissociation Products Segment is Dominating the Cell Dissociation Market:
The Enzymatic Dissociation Products segment is expected to account for a larger revenue share, and the market is expected to grow at a double-digit growth rate over the forecast years. Cell and tissue dissociation, primary cell isolation, and single-cell harvesting are the principal enzymes' principal applications in stem cell research and cell biology studies. The use of enzymes for cell dissociation purposes is widespread. Any dissociation procedure aims to maximize the yield of functionally viable dissociated cells. The outcome of any dissociation procedure depends on (but is not limited to) the type of tissue, age of animal/human, dissociation medium used, an enzyme used, enzyme concentration, temperature, and genetic modifications. Consequently, several enzymes are used in research activities for various purposes. The most prominently used enzymatic dissociation products, in decreasing order of usage frequency, include trypsin, collagenase, elastase, and hyaluronidase, among others.

North America Leads Cell Dissociation Market:
North America is expected to hold a significant market share in the global Cell Dissociation market. It is projected to grow at a prominent growth rate over the forecast years. The key factors driving market expansion include rising cancer and other chronic illness prevalence, as well as a strong trend of R&D spending in life sciences by both industry and academia. In the United States, the federal government granted USD 520 million for the National Cancer Institute (NCI) budget for breast cancer research, USD 800 million for clinical trials, USD 212 million for colorectal cancer research, USD 241 million for leukemia, and another amount over USD 1 billion for research in other cancer types.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players

Global Cell Dissociation market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In 2021, Roche Diagnostics Signed contract with GenMark Diagnostics to access novel technologies to test for a broad range of pathogens in one patient sample.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=337496

Key players' profiles in the Cell Dissociation Market report are VitaCyte, LLC, BD, Thermo Fisher Scientific Inc., PAN-Biotech, Merck KGaA, HiMedia Laboratories, Miltenyi Biotec GmbH, STEMCELL Technologies Inc., General Electric Company, ATCC.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.